Browse studies

Find your next paid study

3,220 recruiting studies matching your filters

A Phase I Study of Zanzalintinib With Pembrolizumab and Cetuximab in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

This Phase I clinical trial evaluates the safety, tolerability, and optimal dosing of Zanzalintinib in combination with Pembrolizumab and Cetuximab in patients…

Head and Neck NeoplasmsCarcinoma, Squamous CellNeoplasm Recurrence, Local+3 more

Estimated

~$150 – $3,000

Actual pay is set by the research site.

University of ChicagoNCT06912087

Observational

Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR Trial

The aim of this study is to learn whether the early initiation of a specialized and focused type of radiation called stereotactic body radiation therapy (SBRT)…

Adenoid Cystic CarcinomaMetastatic Adenoid Cystic Carcinoma

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Dana-Farber Cancer InstituteNCT04883671

Prospective Data Registry and Quality of Life Assessment of PatientsUndergoing Radiotherapy With the RefleXion Medical Radiotherapy System (PREMIER Registry)

The purpose of this prospective cohort study is to assess clinical and quality of life measures as well as to define the severity of adverse effects for the us…

CancerCancer Central Nervous SystemCancer Thoracic+5 more

Estimated

~$10 – $1,125

Actual pay is set by the research site.

RefleXion MedicalNCT05406167

Phase 1

A First-in-Human, Phase I/II PET Imaging Study of 64Cu-GRIP B, a Radiotracer Targeting Granzyme B, in Patients With Advanced Malignancies

This phase I/II clinical trial evaluates if using a radiotracer targeting granzyme B, 64-copper granzyme targeting restricted interaction peptide specific to f…

Prostate CancerRenal CancerUrethral Cancer+3 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Rahul AggarwalNCT05888532

Observational

Resilience in Reentry: Cognitive-Behavioral Resilience Training for Parolees With Adjustment Challenges

This pilot study assesses the feasibility and acceptability of delivering a brief Cognitive-Behavioral Resiliency treatment to a population of recently release…

Adjustment

Estimated

~$10 – $750

Actual pay is set by the research site.

University of California, IrvineNCT07167719

LaserEn: SOLTIVE™ Thulium Laser Fiber En Bloc Resection of Bladder Tumors

Conventional monopolar or bipolar transurethral resection of bladder tumors is the most common method for resection of a bladder mass. En bloc resection has de…

Bladder CancerSurgery

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Kansas Medical CenterNCT04979156

Phase 2

A Phase 2 Open-Label, Multicenter Clinical Study of the Safety, Efficacy, Pharmacokinetic, and Pharmacodynamic Profiles of CGT9486 as a Single Agent in Patients With Advanced Systemic Mastocytosis

This is an open-label, two-part Phase 2 study investigating CGT9486 for the treatment of patients with Advanced Systemic Mastocytosis (AdvSM), including patien…

Advanced Systemic Mastocytosis (AdvSM)SM With an Associated Hematologic Neoplasm (SM-AHN)Mast Cell Leukemia (MCL)+1 more

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Cogent Biosciences, Inc.NCT04996875

Phase 2

Genetically-informed Therapy for ER+ Breast Cancer in a Post-CDK4/6 Inhibitor Setting: a Phase II Umbrella Study (GERTRUDE)

The purpose of this study is to learn if certain drug combinations are effective treatments for patients with advanced ER+/HER2- who have previously been treat…

Advanced Breast Cancer

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Dartmouth-Hitchcock Medical CenterNCT05933395

Observational

Beating Lung Cancer in Ohio (BLCIO) Protocol

This randomized clinical trial studies the Beating Lung Cancer in Ohio protocol in improving survival in patients with stage IV non-small cell lung cancer. The…

Cigarette SmokerCurrent SmokerLung Adenocarcinoma+2 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Ohio State University Comprehensive Cancer CenterNCT03199651

Phase 2

A Phase 2 Study of Loncastuximab Tesirine Plus Mosunetuzumab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

This phase II trial studies the safety and how well of loncastuximab tesirine when given together with mosunetuzumab works in treating patients with diffuse la…

Recurrent Diffuse Large B-Cell LymphomaRecurrent Grade 3b Follicular LymphomaRecurrent High Grade B-Cell Lymphoma+9 more

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Phase 1

A Phase 1/1b Open-Label, Multicenter, First-in-Human Study Evaluating Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of RGT-490 as a Single Agent in Adult Subjects With Locally Advanced or Metastatic PIK3CA-Mutated Solid Tumors Including HR+/HER2- Breast Cancers

This is a phase 1/1b, open-label, multicenter study consisting of sequential parts designed to evaluate the safety, tolerability, and effects pharmacokinetic (…

Breast CancerOvarian CancerEndometrial Cancer+6 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Regor Pharmaceuticals Inc.NCT07524322

Phase 1

A Phase 1 Dose Escalation and Expansion Study of ABL503, a Bispecific Antibody of 4-1BB and PD-L1, As a Single Agent in Subjects with Any Progressive Locally Advanced (unresectable) or Metastatic Solid Tumors

This is a first-in-human Phase 1, single-arm, open-label, multicenter, multiple-dose, dose-escalation and dose-expansion study of ABL503 to evaluate the safety…

Advanced Solid Tumor

Estimated

~$150 – $4,200

Actual pay is set by the research site.

ABL Bio, Inc.NCT04762641